ImmunityBio commands a premium valuation on the promise of Anktiva, a chemo-free immunotherapy platform showing early efficacy and manageable safety. Learn more about IBRX stock here.

Alibaba's capex, especially in AI infrastructure, remains elevated and may continue to suppress free cash flow. Read why BABA stock is rated a Hold.

Reliable, supervised and traceable settlement under shifting political and regulatory rules and why, explains Teresa Cameron, the competitive advantage now lies in ‘fiat resilience’ ...